Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals-Reference-Cited by-同舟云学术

Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals

Published:2022-07 Issue:7 Volume:28 Page:667-672
ISSN:1530-891X
Container-title:Endocrine Practice
language:en
Short-container-title:Endocrine Practice

Author:

Quek Jingxuan,Ng Cheng Han,Tang Ansel Shao Pin,Chew Nicholas,Chan Mark,Khoo Chin Meng,Wei Chen Poh,Chin Yip Han,Tay Phoebe,Lim Grace,Tan Darren Jun Hao,Lim Wen Hui,Chan Kai En,Teng Margaret,Tan Eunice,Tamaki Nobuharu,Huang Daniel Q.,Siddiqui Mohammad Shadab,Young Dan Yock,Noureddin Mazen,Muthiah Mark D.^ORCID

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference52 articles.

1. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease;Ludwig;Mayo Clin Proc,1980

2. Mallory bodies in alcoholic and non-alcoholic liver disease contain a common antigenic determinant;Fleming;Gut,1981

3. The global NAFLD epidemic;Loomba;Nat Rev Gastroenterol Hepatol,2013

4. Past, present and future perspectives in nonalcoholic fatty liver disease;Sanyal;Nat Rev Gastroenterol Hepatol,2019

5. From NAFLD to MAFLD: when pathophysiology succeeds;Tilg;Nat Rev Gastroenterol Hepatol,2020

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: an international multidisciplinary expert consensus;Metabolism;2024-09

2. A potential novel stratification model to predict cardiovascular disease in patients with metabolic dysfunction-associated steatotic liver disease;European Journal of Internal Medicine;2024-09

3. Acute-on-chronic liver failure in metabolic dysfunction-associated fatty liver disease patients: a disease multiplier;Hepatology International;2024-08-06

4. Resmetirom: New Drug, Familiar Challenges?;Endocrine Practice;2024-08

5. Fatty liver as a risk factor for cardiovascular diseases. Retrospective analysis of data from patients of the Geriatrics Clinic of University Clinical Hospital in Wrocław;Medycyna Pracy;2024-07-12